摘要
目的探讨药事与临床用药监管对于提高用药应用合理性和安全性的影响。方法选取我院2017年7月—2018年6月收治的350例患者作为研究对象,将加强药事与临床用药监管后(2018年1—6月)收治的178例患者作为观察组,将加强药事与临床用药监管前(2017年7—12月)收治的172例患者作为对照组,对比两组患者的用药情况。结果观察组用药差错发生率为1.69%,低于与对照组的9.30%,组间比较,差异具有统计学意义(P <0.05),观察组在药物储存、调配、处方审查以及用药安全教育等方面的质量评分均高于对照组,差异具有统计学意义(P <0.05)。结论加强药事与临床用药监管,能够进一步提升药物临床应用的合理性,有效治疗疾病的同时,减少风险事件的发生,为患者的健康安全提供更好的保障。
Objective to explore the influence of drug affairs and clinical drug regulation on improving the rationality and safety of drug application.Methods 350 patients admitted to our hospital from July 2017 to June 2018 were selected as the study subjects.178 patients admitted to our hospital from January to June 2018 after strengthening the supervision of pharmacy and clinical medication were taken as observation group.172 patients admitted before strengthening the supervision of pharmacy and clinical medication from July to December 2017 were taken as control group.The drug use of the two groups was compared.Results The incidence of medication errors in the observation group was 1.69%,which was lower than 9.30%in the control group.There was a significant difference between the two groups(P<0.05).The quality scores of drug storage,dispensing,prescription review and drug safety education in the observation group were higher than those in the control group,with statistical significance(P<0.05).Conclusion Strengthening the supervision of pharmacy and clinical drug use can further enhance the rationality of drug clinical application,effectively treat diseases,reduce the occurrence of risk events,and provide better protection for patients'health and safety.
作者
黄小玉
HUANG Xiaoyu(Pharmaceutical Department,Quanzhou First Hospital Affiliated to Fujian Medical University,Quanzhou Fujian 362000,China)
出处
《中国卫生标准管理》
2019年第4期100-102,共3页
China Health Standard Management
关键词
药事监管
临床用药
安全性
合理性
差错
预防
drug supervision
clinical drug use
safety
rationality
error
prevention